Evidence map›Paper›PMID 22952236›Full record

ArticleThe Journal of biological chemistry2012

Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Na Lian, Tonghui Lin, Wenguang Liu, Weiguang Wang, Lingzhen Li, Stephanie Sun, Jeffry S Nyman, Xiangli Yang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Hop2 Interacts with ATF4 to Promote Osteoblast Differentiation.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Immunology of Gut-Bone Signaling.Advances in experimental medicine and biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Na LianVanderbilt Center for Bone Biology, Nashville, Tennessee 37232, USA.
Tonghui Lin
Wenguang Liu
Weiguang Wang
Lingzhen Li
Stephanie Sun
Jeffry S Nyman
Xiangli Yang
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

ATF4 is Downstream Effector of Bone Anabolic Growth FactorsR03DE017111 · NIDCR · VANDERBILT UNIVERSITY · PI YANG, XIANGLI · 2006 to 2007
$147k
NIDCR NIH HHS R03 DE017111
6 · The paper itself

Abstract

ATF4 is an osteoblast-enriched transcription factor of the leucine zipper family. We recently identified that vimentin, a leucine zipper-containing intermediate filament protein, suppresses ATF4-dependent osteocalcin (Ocn) transcription and osteoblast differentiation. Here we show that TGFβ inhibits ATF4-dependent activation of Ocn by up-regulation of vimentin expression. Osteoblasts lacking Atf4 (Atf4(-/-)) were less sensitive than wild-type (WT) cells to the inhibition by TGFβ on alkaline phosphatase activity, Ocn transcription and mineralization. Importantly, the anabolic effect of a monoclonal antibody neutralizing active TGFβ ligands on bone in WT mice was blunted in Atf4(-/-) mice. These data establish that ATF4 is required for TGFβ-related suppression of Ocn transcription and osteoblast differentiation in vitro and in vivo. Interestingly, TGFβ did not directly regulate the expression of ATF4; instead, it enhanced the expression of vimentin, a negative regulator of ATF4, at the post-transcriptional level. Accordingly, knockdown of endogenous vimentin in 2T3 osteoblasts abolished the inhibition of Ocn transcription by TGFβ, confirming an indirect mechanism by which TGFβ acts through vimentin to suppress ATF4-dependent Ocn activation. Furthermore, inhibition of PI3K/Akt/mTOR signaling, but not canonical Smad signaling, downstream of TGFβ, blocked TGFβ-induced synthesis of vimentin, and inhibited ATF4-dependent Ocn transcription in osteoblasts. Thus, our study identifies that TGFβ stimulates vimentin production via PI3K-Akt-mTOR signaling, which leads to suppression of ATF4-dependent Ocn transcription and osteoblast differentiation.

Indexed as

Activating Transcription Factor 4AnimalsCell DifferentiationCell Line, TumorChlorocebus aethiopsCOS CellsMiceMice, KnockoutOsteoblastsOsteocalcinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsSignal TransductionSmad ProteinsTOR Serine-Threonine KinasesActivating Transcription Factor 4Atf4 protein, mouseAtf4 protein, ratmTOR protein, mousemTOR protein, ratOsteocalcinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSmad ProteinsTOR Serine-Threonine KinasesTransforming Growth Factor betaVimentin

Identifiers

PMID22952236
PMCPMC3476265
OpenAlexW2019781550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.